BioForward Member News

02Apr 2020

Read the full press release from Amgen here. Amgen (NASDAQ:AMGN) and Adaptive Biotechnologies (NASDAQ:ADPT) today announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and develop fully human neutralizing antibodies targeting SARS-CoV-2 to potentially prevent or treat COVID-19. The mutually exclusive collaboration brings together Adaptive’s proprietary immune medicine […]

02Apr 2020

Read the full story from BizTimes here. Milwaukee-based Versiti, Inc. will soon begin collecting plasma from recovered COVID-19 patients to potentially treat those with the virus. As researchers race to develop vaccines and treatments for COVID-19, blood centers across the country are beginning to collect plasma for the investigational therapy, which is expected to be […]

30Mar 2020

Read the full story from BizTimes here. Wisconsin Gov. Tony Evers announced on Monday a new public-private partnership that is expected to double the state’s current COVID-19 testing capacity. Under the partnership, labs operated by Madison-based Exact Sciences Corp., Marshfield Clinic Health System, Madison-based Promega Corp. and UW Health will join an existing network of […]

03Feb 2020

Read the full story from BizJournals here. Cancer diagnostics company Exact Sciences Corp. has more than doubled the capital investment and job creation numbers it proposed under an agreement with the Wisconsin Economic Development Corp., according to documents obtained by the Milwaukee Business Journal per a public records request. In 2015, Madison-based Exact Sciences was approved […]

22Jan 2020

Read the full story from WISCONSIN INNO here. The University of Wisconsin-Milwaukee and Froedtert & the Medical College of Wisconsin have partnered on an app that provides real-time communication between doctors that treat patients whose cancer has spread to the brain. The app, called NIMBLE, also provides data-driven treatment recommendations for doctors and references to […]

13Jan 2020

Read the full press release on Business Wire here. Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Roche, a global pioneer in pharmaceuticals and diagnostics, today announced a 15-year, non-exclusive collaboration agreement to broaden the adoption of distributable next-generation sequencing-based (NGS) testing in oncology. As the understanding of genomic […]

09Jan 2020

Read the full press release from Empirico here. Empirico Inc. announced today that it has entered into a strategic collaboration with Ionis Pharmaceuticals. During the three-year collaboration, Empirico will utilize its Precision Insights Platform, which incorporates huge biological data sets, human genetics and advanced algorithmic approaches, to identify therapeutic targets for indications and tissues that are amenable […]